Shobhona Sharma
#68,451
Most Influential Person Now
Indian molecular parasitologist
Shobhona Sharma's AcademicInfluence.com Rankings
Shobhona Sharmabiology Degrees
Biology
#2999
World Rank
#4654
Historical Rank
Parasitology
#77
World Rank
#91
Historical Rank
Molecular Biology
#513
World Rank
#525
Historical Rank
Download Badge
Biology
Shobhona Sharma's Degrees
- Masters Biotechnology Delhi University
- Bachelors Biotechnology Delhi University
Why Is Shobhona Sharma Influential?
(Suggest an Edit or Addition)According to Wikipedia, Shobhona Sharma is a professor specializing in immunology, molecular biology, and biochemistry at the Tata Institute of Fundamental Research, Mumbai. She is also the chairperson of the Department of Biological Sciences. She is a Fellow of the Indian Academy of Sciences and the Indian National Science Academy.
Shobhona Sharma's Published Works
Published Works
- Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. (2008) (158)
- Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. (2010) (112)
- Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. (2012) (107)
- Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. (2008) (103)
- Distinct Th1- and Th2-Type Prenatal Cytokine Responses to Plasmodium falciparum Erythrocyte Invasion Ligands (2005) (99)
- Malaria parasite‐infected erythrocytes inhibit glucose utilization in uninfected red cells (2005) (78)
- Protective Properties and Surface Localization of Plasmodium falciparum Enolase (2007) (72)
- Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization (2009) (68)
- Age-Dependent Sex Bias in Clinical Malarial Disease in Hypoendemic Regions (2012) (63)
- Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. (2008) (62)
- Cloning, over-expression, purification and characterization of Plasmodium falciparum enolase. (2004) (61)
- Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities. (2006) (58)
- Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a ¹H NMR spectroscopy-based metabonomic study. (2012) (57)
- Surface expression of the conserved ribosomal protein P0 on parasite and other cells. (2002) (56)
- The P Domain of the P0 Protein of Plasmodium falciparum Protects against Challenge with Malaria Parasites (2004) (49)
- Tank treading of optically trapped red blood cells in shear flow. (2011) (46)
- Antibodies against Ribosomal Phosphoprotein P0 ofPlasmodium falciparum Protect Mice against Challenge with Plasmodium yoelii (2000) (46)
- Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression (2010) (44)
- Malaria vaccine: a current perspective. (2008) (43)
- Measuring erythrocyte deformability with fluorescence, fluid forces, and optical trapping. (2008) (43)
- Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies. (2012) (37)
- Naturally occurring, optically driven, cellular rotor (2004) (35)
- Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study (2011) (32)
- Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria. (2016) (32)
- Single episode of mild murine malaria induces neuroinflammation, alters microglial profile, impairs adult neurogenesis, and causes deficits in social and anxiety-like behavior (2014) (31)
- Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency. (2016) (31)
- Translocation of ribosomal protein P0 onto the Toxoplasma gondii tachyzoite surface. (2003) (29)
- Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria. (2014) (28)
- Host metabolic responses to Plasmodium falciparum infections evaluated by 1H NMR metabolomics. (2016) (28)
- Plant-like phosphofructokinase from Plasmodium falciparum belongs to a novel class of ATP-dependent enzymes. (2009) (25)
- Evidence of IL-17, IP-10, and IL-10 involvement in multiple-organ dysfunction and IL-17 pathway in acute renal failure associated to Plasmodium falciparum malaria (2015) (25)
- Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0. (2005) (24)
- Arrest of Nuclear Division in Plasmodium through Blockage of Erythrocyte Surface Exposed Ribosomal Protein P2 (2012) (23)
- Early prediction of cerebral malaria by 1H NMR based metabolomics (2016) (22)
- Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers. (2014) (22)
- Self-Microemulsifiyng Suppository Formulation of β-Artemether (2010) (21)
- Multifaceted Role of Heme during Severe Plasmodium falciparum Infections in India (2015) (20)
- Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model. (2013) (19)
- Bioavailability enhancement of atovaquone using hot melt extrusion technology. (2016) (19)
- Enhanced antimalalarial activity of a prolonged release in situ gel of arteether–lumefantrine in a murine model (2018) (18)
- Multivariate modelling with 1H NMR of pleural effusion in murine cerebral malaria (2011) (18)
- Sera from Lupus Patients Inhibit Growth of P. Falciparum in Culture (2001) (17)
- Shape anisotropy induces rotations in optically trapped red blood cells. (2010) (16)
- Atovaquone oral bioavailability enhancement using electrospraying technology (2018) (16)
- Metabolic Perturbations of Kidney and Spleen in Murine Cerebral Malaria: 1H NMR-Based Metabolomic Study (2013) (16)
- Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region* (2016) (16)
- Characterization of P0, a Ribosomal Phosphoprotein ofPlasmodium falciparum (1997) (14)
- Membrane and luminal proteins reach the apicoplast by different trafficking pathways in the malaria parasite Plasmodium falciparum (2017) (13)
- 1H NMR Metabonomics Indicates Continued Metabolic Changes and Sexual Dimorphism Post-Parasite Clearance in Self-Limiting Murine Malaria Model (2013) (13)
- Metabolomic changes in vertebrate host during malaria disease progression (2018) (13)
- NMR Insights into Folding and Self-Association of Plasmodium falciparum P2 (2012) (13)
- Liver Metabolic Alterations and Changes in Host Intercompartmental Metabolic Correlation during Progression of Malaria (2011) (13)
- Vivax infection alters peripheral B‐cell profile and induces persistent serum IgM (2018) (12)
- Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation. (2012) (12)
- Host responses in malaria disease evaluated through nuclear magnetic resonance-based metabonomics. (2012) (12)
- Ribosomal protein P2 localizes to the parasite zoite-surface and is a target for invasion inhibitory antibodies in Toxoplasma gondii and Plasmodium falciparum. (2015) (11)
- Plasmodium-infected red blood cells exhibit enhanced rolling independent of host cells and alter flow of uninfected red cells (2005) (11)
- On the birefringence of healthy and malaria-infected red blood cells (2013) (11)
- Erythrocytic Stage-dependent Regulation of Oligomerization of Plasmodium Ribosomal Protein P2* (2012) (10)
- Glutathione and thioredoxin systems of the malaria parasite Plasmodium falciparum: partners in crime? (2017) (10)
- Cell-density-dependent changes in the metabolism of chloronema cell cultures (1979) (9)
- Correction: Arrest of Nuclear Division in Plasmodium through Blockage of Erythrocyte Surface Exposed Ribosomal Protein P2 (2012) (9)
- Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0 (2004) (8)
- Metabolomic analysis of urine samples of vivax malaria in-patients for biomarker identification (2015) (8)
- Characterization of a differential immunoscreen epitope of Plasmodium falciparum using combinatorial agents (2000) (7)
- Early Perturbations in Glucose Utilization in Malaria-Infected Murine Erythrocytes, Liver and Brain Observed by Metabolomics (2020) (7)
- Generation and characterisation of monoclonal antibodies specific to Plasmodium falciparum enolase. (2006) (7)
- Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India (2016) (7)
- Laser-Driven Accelerated Growth of Dendritic Patterns in Liquids (2012) (6)
- Heterozygous mutants of TIRAP (S180L) polymorphism protect adult patients with Plasmodium falciparum infection against severe disease and mortality. (2016) (6)
- Malaria in India: The Need for New Targets for Diagnosis and Detection of Plasmodium vivax (2018) (6)
- Residue level description of In vivo self-association of Plasmodium falciparum P2 (2014) (6)
- How specific is the immune response to malaria in adults living in endemic areas? (2003) (6)
- Molten globule nature of Plasmodium falciparum P2 homo-tetramer (2015) (5)
- A history of juvenile mild malaria exacerbates chronic stress-evoked anxiety-like behavior, neuroinflammation, and decline of adult hippocampal neurogenesis in mice (2020) (5)
- The C-terminal domain of eukaryotic acidic ribosomal P2 proteins is intrinsically disordered with conserved structural propensities. (2015) (4)
- Teratogenicity of Artemether–Clindamycin Nanostructured Lipid Carriers in Rats (2016) (4)
- A Urine 1H NMR based metabonomic approach to understand the host metabolic response towards Plasmodium vivax infection (2010) (3)
- Plasmodium Riboprotein PfP0 Induces a Deviant Humoral Immune Response in Balb/c Mice (2012) (3)
- Cyclic AMP phosphodiesterases of Funaria hygrometrica (1983) (3)
- Molecular study of binding of Plasmodium ribosomal protein P2 to erythrocytes. (2020) (3)
- Study of P. falciparum-infected erythrocytes and induced anisotropies under optical and fluid forces. (2007) (2)
- A primate specific loss of function polymorphism in TLR2 gene decreases inflammation and protects humans from organ dysfunction in Malaria (2017) (2)
- 5′-Untranslated region of a ribosomal phosphoprotein gene of Plasmodium falciparum. (2000) (2)
- Evaluation of yield level and stability performance of soybean genotypes. (1980) (1)
- Brain and Hepatic Glucose Utilization in Malarial Infection Does Not Depend on Cerebral Symptoms of the Disease (2019) (1)
- Surface expressed Plasmodium circumsporozoite protein (CSP) modulates cellular flexibility and motility (2021) (1)
- Developmentally regulated oligomerization of Plasmodium P 2 protein 1 Erythrocytic stage dependent regulation of oligomerization of Plasmodium ribosomal protein P 2 (2012) (0)
- Cell-density-dependent Changes in the Metabolism of Chloronema (1979) (0)
- Diversity in two candidate malaria vaccine antigens in different Indian strains ofPlasmodium falciparum (1994) (0)
- Membrane and luminal proteins reach the apicoplast by different trafficking pathways in the malaria parasite [i]Plasmodium falciparum[i] (2017) (0)
- Characterisation of a conserved putative protective epitope of plasmodium falciparum (1998) (0)
- Sir Ronald Ross and the malarial parasite (2006) (0)
- Metabolomic analysis of urine samples of vivax malaria in-patients for biomarker identification (2015) (0)
- Evidence of IL-17, IP-10, and IL-10 involvement in multiple-organ dysfunction and IL-17 pathway in acute renal failure associated to Plasmodium falciparum malaria (2015) (0)
- Expression of selected domains of the circumsporozoite antigen ofPlasmodium knowlesi (1992) (0)
- Translation and post-translational modifications in Plasmodium (2012) (0)
- Immunological cross reactivity of protective Plasmodium epitope with Paramecium surface antigen. (2000) (0)
- Early prediction of cerebral malaria by 1H NMR based metabolomics (2016) (0)
- Erratum: “A naturally-occurring, optically-driven, cellular rotor” [Appl. Phys. Lett. 85, 6048 (2004)] (2005) (0)
- European Workshop on Particulate Systems Berlin 2008 One Decade of EWPS Program 30 th and 31 st May 2008 (2008) (0)
- Corrigendum to article "Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies" [Int. J. Pharm. 431(1-2) (2012) 149-160]. (2022) (0)
- 152 Molten globule behavior of apicomplexan protein P2 from Plasmodium falciparum and Toxoplasma gondii (2015) (0)
- Erythrocyte Membrane Protein-1 (PfEMP1), Acyl Carrier Protein (ACP) and glutathione (2019) (0)
This paper list is powered by the following services:
Other Resources About Shobhona Sharma
What Schools Are Affiliated With Shobhona Sharma?
Shobhona Sharma is affiliated with the following schools: